Gyeonggi-do, South Korea

Changmin Hyun

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 112(Granted Patents)


Location History:

  • Seoul, KR (2004)
  • Gyeonggi-do, KR (2021)
  • Anyang-si, KR (2024)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Changmin Hyun: Innovator in Hemoglobin Derivatives

Introduction

Changmin Hyun is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical innovations, particularly in the development of hemoglobin derivatives. With a total of 4 patents to his name, his work is paving the way for advancements in blood substitutes.

Latest Patents

One of Changmin Hyun's latest patents is focused on a hemoglobin derivative co-conjugated with fatty acid-linked polyethylene glycol (FA-PEG) and alkoxy polyethylene glycol (alkoxy-PEG). This invention relates to a method for creating a hemoglobin derivative that exhibits non-toxicity and an extended intravascular retention time. Another significant patent involves a novel monofunctional polyethylene glycol (PEG) modified with a siloxy group, offering an alternative to traditional methoxy polyethylene glycol.

Career Highlights

Changmin Hyun is currently associated with Sun Bio, Inc., where he continues to innovate in the field of biomedicine. His work is characterized by a commitment to developing safer and more effective blood substitutes, which could have a profound impact on medical treatments.

Collaborations

He collaborates with talented individuals such as Kwang Nho and Junghoon Lee, contributing to a dynamic research environment that fosters innovation.

Conclusion

Changmin Hyun's contributions to the field of hemoglobin derivatives highlight his role as a leading inventor in biomedicine. His innovative patents are set to make a significant impact on the future of blood substitutes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…